Lead ongoing clinical data review to ensure quality, interpretation, and patient safety across development programs.
Develop and review study protocols, investigator brochures, and regulatory documents in partnership with cross-functional teams.
Represent Clinical Development on study teams and present clinical data and scientific information to internal and external audiences.
Deciphera, a member of Ono Pharmaceutical Co., Ltd., is a biopharmaceutical company discovering, developing, and commercializing new medicines for cancer, neurologic, and autoimmune disease. They cultivate an inclusive culture valuing curiosity, creativity, and shared accountability, empowering individuals to challenge the unknown together.
Serve as a scientific liaison to key opinion leaders and healthcare providers in stem cell transplantation and cellular therapy within the Great Lakes territory.
Develop and maintain deep peer-to-peer relationships with academic experts while gathering insights to inform medical strategy and evidence generation.
Lead scientific exchange, support investigator-sponsored trials, and provide education on Orca Bio's next-generation cell therapies.
Orca Bio is a commercial-stage biotechnology company developing next-generation cell therapies to replace traditional stem cell transplants for blood cancer patients. The company maintains a start-up culture of camaraderie, leadership by example, and is driven by passion, courage, and integrity.
Partner with Clinical Development leads to shape translational and clinical science strategy for BHB-1893 across oHCM and nHCM.
Lead scientific input into protocol design, clinical data review, and independent analysis of biomarker and exploratory endpoint data.
Serve as key clinical science point of contact for global co-development partnership and represent science externally with KOLs.
Braveheart Bio is a clinical-stage biopharmaceutical company developing therapies for hypertrophic cardiomyopathy and other cardiovascular diseases. The company has a proven leadership team, strong financial foundation, and a mission-driven culture.
Support clinical development strategies and study execution across Phase 1-3 programs.
Oversee clinical safety and data review, partnering with CROs and internal teams to ensure quality.
Contribute to protocols, regulatory documents, and study reports for respiratory disease therapies.
Celea Therapeutics is a biopharmaceutical company dedicated to advancing transformative treatments for serious respiratory diseases, with its lead program in Phase 3 clinical development. As an early-stage, mission-driven team, Celea values accountability, transparency, collaboration, innovation, and passion.